“"We are deeply grateful for the opportunity to partner with you for the sale of our company. We hadn't previously realized that our business was in such a niche industry, but with your patience and expertise, we were so pleased to close a transaction with a local private-equity group with the energy, expertise and experience to take the company to the next level.

Your professionalism and dedication to seeing this transaction through made the biggest difference to our positive experience throughout this process. We always felt that you both were the true partners in this engagement, and we are so glad that we had the opportunity to work with you and your team at Zachary Scott."”
Raymond & Margaret Suen, Co-founders, US BioTek Laboratories
Service BusinessM&A: Sell-Side
Follow by Email
Facebook
Twitter
Share
Situation

US BioTek Laboratories, Inc. (“US BioTek” or the “Company”) is a leading laboratory specializing in testing for food-related allergies and intolerances. Headquartered in Shoreline, Washington, US BioTek’s testing facility provides a variety of immunology and chemistry profiles to naturopaths, clinics, and physicians around the world.

ZS Role

Zachary Scott was retained on an exclusive basis to represent the shareholders in their search for a partner that would further advance the growth and success of the business while allowing the owners to move into advisory roles.

Results

Zachary Scott organized a competitive sale process that attracted a range of bids from industry participants and qualified financial buyers. The sale of the Company was consummated with Pike Street Capital, a private equity firm based in Seattle, Washington. Pike Street Capital’s investment and partnership will help US BioTek expand its testing services and reach a growing global customer base.